mhurhangee/ep-ind-claims huggingface dataset:
A transportation unit comprising: a frame; a plurality of wheels attached to the frame; and a retractable wheel system comprising: a rotatable member attached to the frame; a swing arm comprising a first end attached to the rotatable member and a second end attached to a wheel; a swing mount attached to the rotatable member; and a spring member having a first end attached to the swing mount at a connection point and a second end attached to the second end of the swing arm, such that the spring member is rotatable relative to the swing mount at the connection point, wherein the spring member is configured to apply a force in a downward direction when the connection point is above a line extending between a wheel attachment point and a swing arm rotation point, wherein the wheel of the retractable wheel system is positioned between the plurality of wheels, wherein the line extends through an axis or centerline of the swing arm, and further comprising a first extended position in which the connection point is above the line and a second retracted position in which the connection point is below the line, wherein rotation of the rotatable member is configured to move the system between the first extended position to the second retracted position, and wherein the transportation unit is a medical bed. a frame; a plurality of wheels attached to the frame; and a retractable wheel system comprising: a rotatable member attached to the frame; a swing arm comprising a first end attached to the rotatable member and a second end attached to a wheel; a swing mount attached to the rotatable member; and a spring member having a first end attached to the swing mount at a connection point and a second end attached to the second end of the swing arm, such that the spring member is rotatable relative to the swing mount at the connection point, a rotatable member attached to the frame; a swing arm comprising a first end attached to the rotatable member and a second end attached to a wheel; a swing mount attached to the rotatable member; and a spring member having a first end attached to the swing mount at a connection point and a second end attached to the second end of the swing arm, such that the spring member is rotatable relative to the swing mount at the connection point, wherein the spring member is configured to apply a force in a downward direction when the connection point is above a line extending between a wheel attachment point and a swing arm rotation point, wherein the wheel of the retractable wheel system is positioned between the plurality of wheels, wherein the line extends through an axis or centerline of the swing arm, and further comprising a first extended position in which the connection point is above the line and a second retracted position in which the connection point is below the line, wherein rotation of the rotatable member is configured to move the system between the first extended position to the second retracted position, and wherein the transportation unit is a medical bed.
Medical unit for injecting a patient with an elution solution containing rubidium-82, which medical unit comprises: (a) means for receiving a strontium/rubidium generator adapted to produce an elution solution that contains said rubidium-82 and that is liable to be contaminated with strontium-82 and/or strontium-85, (b) means for perfusing the patient with said elution solution, comprising an injection catheter and operable by control means to two positions: (i) a perfusion position, in which said elution solution is intended to circulate from said strontium/rubidium generator to said injection catheter intended to be connected to the patient, and (ii) a stop position, in which the circulation of said elution solution is intended to be blocked at least within said injection catheter, to prevent an injection of the patient with said elution solution, characterized in that it also comprises (c) its own means for acquiring a value relating to at least one security parameter that is associated with a maximum threshold value corresponding to a potentially excessive contamination of said elution solution with strontium-82 and/or strontium-85, and in that said control means include security means that are piloted to an active configuration when said acquired value reaches said maximum threshold value of said security parameter, said security means in active configuration being adapted to pilot said perfusion means to said stop position, in order to prevent an injection of the patient with said elution solution. (a) means for receiving a strontium/rubidium generator adapted to produce an elution solution that contains said rubidium-82 and that is liable to be contaminated with strontium-82 and/or strontium-85, (b) means for perfusing the patient with said elution solution, comprising an injection catheter and operable by control means to two positions: (i) a perfusion position, in which said elution solution is intended to circulate from said strontium/rubidium generator to said injection catheter intended to be connected to the patient, and (ii) a stop position, in which the circulation of said elution solution is intended to be blocked at least within said injection catheter, to prevent an injection of the patient with said elution solution, (i) a perfusion position, in which said elution solution is intended to circulate from said strontium/rubidium generator to said injection catheter intended to be connected to the patient, and (ii) a stop position, in which the circulation of said elution solution is intended to be blocked at least within said injection catheter, to prevent an injection of the patient with said elution solution,
A crystal A of a compound represented by formula I: wherein an X-ray diffraction pattern of the crystal A of the compound represented by formula I has diffraction peaks at 2θ of 9.35°±0.2°, 11.93°±0.2°, 16.32°±0.2°, 21.23°±0.2°, 23.13°±0.2° and 25.58°±0.2°; typically has diffraction peaks at 2θ of 9.35°±0.2°, 11.93°±0.2°, 16.32°±0.2°, 18.82°±0.2°, 20.54°±0.2°, 21.23°±0.2°, 23.13°±0.2° and 25.58°±0.2°; more typically has diffraction peaks at 2θ of 9.35°±0.2°, 10.93°±0.2°, 11.93°±0.2°, 14.46°±0.2°, 16.32°±0.2°, 18.82°±0.2°, 20.54°±0.2°, 21.23°±0.2°, 21.66°±0.2°, 23.13°±0.2°, 25.58°±0.2° and 26.34°±0.2°; and further typically has diffraction peaks at 2θ of 9.35°±0.2°, 10.93°±0.2°, 11.93°±0.2°, 14.46°±0.2°, 16.32°±0.2°, 17.28°±0.2°, 18.82°±0.2°, 19.25°±0.2°, 20.54°±0.2°, 21.23°±0.2°, 21.66°±0.2°, 22.15°±0.2°, 23.13°±0.2°, 24.09°±0.2°, 25.58°±0.2° and 26.34°±0.2°.
Gene-modified, inflammation-specific monocytes for use in the treatment of one or more than one inflammation-related condition or disease, wherein the gene-modified, inflammation-specific monocytes home specifically to inflamed tissues, and wherein the gene-modified, inflammation-specific monocytes comprise: a) a 1-alpha-hydroxylase gene that produces functional 1-alpha-hydroxylase when the monocytes transdifferentiate into gene-modified, inflammation-specific macrophages, thereby producing calcitriol locally within the inflamed tissue; b) a growth factor gene selected from insulin-like growth factor 1 or transforming growth factor beta that produces functional growth factor when the gene-modified, inflammation-specific monocytes transdifferentiate into gene-modified, inflammation-specific macrophages, where the growth factor acts synergistically with the localized production of calcitriol to suppress inflammation, thereby treating the inflammation-related condition or disease, where the 1-alpha-hydroxylase gene is on plasmid DNA or on a viral vector, or where the growth factor gene is on plasmid DNA or on a viral vector, or where both the 1-alpha-hydroxylase gene and the growth factor gene are on plasmid DNA or on a viral vector; and c) a macrophage-specific promoter which is functional under conditions of inflammation, wherein the macrophage-specific promotor limits the expression of the 1-alpha-hydroxylase gene, wherein the macrophage-specific promoter limits expression of the 1-alpha-hydroxylase gene until the gene-modified, inflammation-specific monocytes transdifferentiate into gene-modified, inflammation-specific macrophages. a) a 1-alpha-hydroxylase gene that produces functional 1-alpha-hydroxylase when the monocytes transdifferentiate into gene-modified, inflammation-specific macrophages, thereby producing calcitriol locally within the inflamed tissue; b) a growth factor gene selected from insulin-like growth factor 1 or transforming growth factor beta that produces functional growth factor when the gene-modified, inflammation-specific monocytes transdifferentiate into gene-modified, inflammation-specific macrophages, where the growth factor acts synergistically with the localized production of calcitriol to suppress inflammation, thereby treating the inflammation-related condition or disease, where the 1-alpha-hydroxylase gene is on plasmid DNA or on a viral vector, or where the growth factor gene is on plasmid DNA or on a viral vector, or where both the 1-alpha-hydroxylase gene and the growth factor gene are on plasmid DNA or on a viral vector; and c) a macrophage-specific promoter which is functional under conditions of inflammation, wherein the macrophage-specific promotor limits the expression of the 1-alpha-hydroxylase gene, wherein the macrophage-specific promoter limits expression of the 1-alpha-hydroxylase gene until the gene-modified, inflammation-specific monocytes transdifferentiate into gene-modified, inflammation-specific macrophages.
A pneumatic deicing device for breaking and removing an ice deposit accumulated on the outer surface of an aircraft, comprising at least: - an outer layer made from polyurethane intended to withstand an outside environment, preferably, - an inner interface layer connected to the outer surface of the aircraft, and - at least two outer and inner intermediate layers connected to one another by an array of stitches spaced apart so as to define deicing chambers that can be inflated quickly using injected pressurized air so as to create an expansion of the device causing a mechanical action to break the ice, the outer intermediate layer being made of a deformable knit textile layer that is elastically deformable under the effect of the inflation, - at least one interlayer (20, 32) or made from polar elastomer material and arranged above the knit textile layer of the outer intermediate layer and immediately in contact with the outer layer and the knit textile layer, characterized in that the polar elastomer material of the intermediate layer (20, 32) or is epichlorohydrin. - an outer layer made from polyurethane intended to withstand an outside environment, preferably, - an inner interface layer connected to the outer surface of the aircraft, and - at least two outer and inner intermediate layers connected to one another by an array of stitches spaced apart so as to define deicing chambers that can be inflated quickly using injected pressurized air so as to create an expansion of the device causing a mechanical action to break the ice, the outer intermediate layer being made of a deformable knit textile layer that is elastically deformable under the effect of the inflation, - at least one interlayer (20, 32) or made from polar elastomer material and arranged above the knit textile layer of the outer intermediate layer and immediately in contact with the outer layer and the knit textile layer, characterized in that the polar elastomer material of the intermediate layer (20, 32) or is epichlorohydrin.
The use of polynucleotides encoding influenza proteins from an H1N1 strain and an H3N2 strain for manufacturing an immunogenic composition or a vaccine component against influenza A infections in humans and pigs, where the polynucleotides code for haemagglutinin and Neuraminidase and matrix protein and the nucleoprotein wherein the polynucleotides encode SEQ ID No. 11 and 13, and SEQ ID No. 6 and 8 or 9 and wherein the DNA or RNA sequences contain codons that are optimised for expression in mammalian cells..
Casing for distributing electrical power for an aircraft comprising a frame containing at least one power connector formed of one or more rails capable of cooperating with an end of a power plate, the power connector being configured such that the rails receive one or more distribution bars of the power plate at the end, said power plate comprising at least one switching element for an electrical energy distribution plate.
A polymerizable composition comprising a cycloolefin-based monomer represented by a formula, and a polymerization catalyst, wherein R 1 is a substituent selected from a group consisting of a hydrocarbon group having 1 to 10 carbon atoms, a halogen atom, and a hydrocarbon group having 1 to 10 carbon atoms that is substituted with a halogen atom, m is an integer from 0 to 6n+6, provided that one or more R 1 are bonded at an arbitrary position when m is equal to or larger than 1, and R 1 are either identical or different when m is equal to or larger than 2, and n is an integer from 1 to 3.
Method for operating a motor vehicle with respect to a parking operation to be performed at a parking space, the motor vehicle having a vehicle system configured to detect and select the parking space to be used from a plurality of candidate parking spaces, characterised in that to at least one candidate parking space there is locally assigned a transmitting device which is in the form of a beacon and which is located in the surroundings of the candidate parking space and from which the motor vehicle receives authorisation information describing the authorisation to park the motor vehicle on the candidate parking space and/or to drive through at least a segment of a route leading to the candidate parking space, the selection of the parking space to be used being made in dependence on the authorisation information, the operation of the motor vehicle during the search for a parking space being completely automatically conducted by the vehicle system.
A method for sterilizing a product, comprising: - providing a first air flow (22A, 22B; 122) to the product to reduce a temperature of the product, said first air flow (22A, 22B; 122) being at a temperature range of -100°C to -80°C, and - providing a second air flow (24A, 24B; 124) to the product after the first air flow (22A, 22B; 122) to heat and thermally shock the product to sterilize any microorganisms on the product, said second air flow (24A, 24B; 124) being at a temperature range of 50°C to 100°C, characterized by filtering an atmosphere resulting from the first air flow (22A, 22B; 122) and from the second air flow (24A, 24B; 124) for removing pathogens and particulate matter from said atmosphere. - providing a first air flow (22A, 22B; 122) to the product to reduce a temperature of the product, said first air flow (22A, 22B; 122) being at a temperature range of -100°C to -80°C, and - providing a second air flow (24A, 24B; 124) to the product after the first air flow (22A, 22B; 122) to heat and thermally shock the product to sterilize any microorganisms on the product, said second air flow (24A, 24B; 124) being at a temperature range of 50°C to 100°C, characterized by filtering an atmosphere resulting from the first air flow (22A, 22B; 122) and from the second air flow (24A, 24B; 124) for removing pathogens and particulate matter from said atmosphere.
A casting core, comprising: a core body; and a tip comb extending from a tip region of the core body and integrally formed with the core body, the tip comb comprising a first casting protrusion and a second casting protrusion, wherein the first casting protrusion and the second casting protrusion define an aperture having a tapered geometry, wherein the first casting protrusion has a first width at a proximal end and a second width at a distal end, characterised in that the second width of the first casting protrusion is greater than the first width. a core body; and a tip comb extending from a tip region of the core body and integrally formed with the core body, the tip comb comprising a first casting protrusion and a second casting protrusion, wherein the first casting protrusion and the second casting protrusion define an aperture having a tapered geometry, wherein the first casting protrusion has a first width at a proximal end and a second width at a distal end, characterised in that the second width of the first casting protrusion is greater than the first width.
Freeze-dried molded article characterized in that it comprises > 50% by wt. of one or more active substances selected from the group of acid active substances having a pKa value of < or equal to 7 at 25°C, and < or equal to 15% by wt. of one or more scaffold-forming agents, with proteins being excepted, as well as optionally one or more auxiliary substances, in each case based on the total composition of the freeze-dried molded article, and whose 1% by wt. solution or suspension in water, at 20 °C., has a pH value of < 7.
A cast product comprising: an aluminum alloy strip; wherein the aluminum alloy strip comprises: 4 wt. % to 28 wt. % zinc; optionally at least one of 1 wt. % to 3 wt. % Cu and 1 wt. % to 3 wt. % Mg; optionally 0.1 wt. % to 1.0 wt. % Mn; optionally 0.05 wt. % to 0.3 wt. % Cr; optionally 0.04 wt. % to 0.25 wt. % Zr; the balance being aluminum and impurities, wherein the aluminum alloy strip has a thickness, wherein the aluminum alloy realizes a zinc variation of not greater than 15% as measured between a surface of the aluminum alloy strip and a center (T/2) of the aluminum alloy strip, wherein the zinc variation is calculated as {(the maximum weight percent of zinc from the surface to the thickness center (T/2) minus (-) the minimum weight percent of zinc from the surface to the thickness center (T/2)) divided by (/) (the mean weight percent of the zinc from the surface to the thickness center (T/2))}*100, wherein the weight percent of zinc is measured according to the macro-segregation procedure disclosed in the description. an aluminum alloy strip; wherein the aluminum alloy strip comprises: 4 wt. % to 28 wt. % zinc; optionally at least one of 1 wt. % to 3 wt. % Cu and 1 wt. % to 3 wt. % Mg; optionally 0.1 wt. % to 1.0 wt. % Mn; optionally 0.05 wt. % to 0.3 wt. % Cr; optionally 0.04 wt. % to 0.25 wt. % Zr; the balance being aluminum and impurities, 4 wt. % to 28 wt. % zinc; optionally at least one of 1 wt. % to 3 wt. % Cu and 1 wt. % to 3 wt. % Mg; optionally 0.1 wt. % to 1.0 wt. % Mn; optionally 0.05 wt. % to 0.3 wt. % Cr; optionally 0.04 wt. % to 0.25 wt. % Zr; the balance being aluminum and impurities, wherein the aluminum alloy strip has a thickness, wherein the aluminum alloy realizes a zinc variation of not greater than 15% as measured between a surface of the aluminum alloy strip and a center (T/2) of the aluminum alloy strip, wherein the zinc variation is calculated as {(the maximum weight percent of zinc from the surface to the thickness center (T/2) minus (-) the minimum weight percent of zinc from the surface to the thickness center (T/2)) divided by (/) (the mean weight percent of the zinc from the surface to the thickness center (T/2))}*100, wherein the weight percent of zinc is measured according to the macro-segregation procedure disclosed in the description.
A communication device of handling power saving; the communication device comprising: a storage unit for storing instructions of: transmitting a first message comprising capability information to an access network, characterised in that the capability information indicates a plurality of power saving modes of the communication device; selecting a power saving mode from the plurality of power saving modes; and transmitting a second message comprising the power saving mode and at least one power saving parameter related to the power saving mode to a core network; and a processing means, coupled to the storage unit, configured to execute the instructions stored in the storage unit. transmitting a first message comprising capability information to an access network, characterised in that the capability information indicates a plurality of power saving modes of the communication device; selecting a power saving mode from the plurality of power saving modes; and transmitting a second message comprising the power saving mode and at least one power saving parameter related to the power saving mode to a core network; and a processing means, coupled to the storage unit, configured to execute the instructions stored in the storage unit.
A method for assessing a thermal path associated with an integrated circuit (102, 202, 302, 402) configured to be connected to a power source, the method comprising: in response to identifying that a heat application mode based on a design type of the integrated circuit (102, 202, 302, 402) is that of a current limit mode: measuring a first temperature of at least one thermal sensing device (106, 206, 306, 406) associated with the integrated circuit (102, 202, 302, 402); applying heat to at least a portion of the integrated circuit (102, 202, 302, 402) according to the heat application mode; measuring a second temperature of the at least one thermal sensing device (106, 206, 306, 406) associated with the integrated circuit (102, 202, 302, 402); determining a difference between the first temperature and the second temperature; and determining whether a thermal path between the integrated circuit and an associated substrate is sufficient based on a comparison of the difference between the first temperature and the second temperature with a predetermined difference between an initial temperature and a subsequent temperature of the at least one thermal sensing device (106, 206, 306, 406) and, wherein the integrated circuit includes a FET and the thermal sensing device connected to a resistor on a low side of the FET and the thermal sensing device and connected to the power source on a high side of the FET and the thermal sensing device, the resistor being disposed on a PCB external from the integrated circuit and connected to ground on a side of the resistor opposite the FET and the thermal sensing device. measuring a first temperature of at least one thermal sensing device (106, 206, 306, 406) associated with the integrated circuit (102, 202, 302, 402); applying heat to at least a portion of the integrated circuit (102, 202, 302, 402) according to the heat application mode; measuring a second temperature of the at least one thermal sensing device (106, 206, 306, 406) associated with the integrated circuit (102, 202, 302, 402); determining a difference between the first temperature and the second temperature; and determining whether a thermal path between the integrated circuit and an associated substrate is sufficient based on a comparison of the difference between the first temperature and the second temperature with a predetermined difference between an initial temperature and a subsequent temperature of the at least one thermal sensing device (106, 206, 306, 406) and, wherein the integrated circuit includes a FET and the thermal sensing device connected to a resistor on a low side of the FET and the thermal sensing device and connected to the power source on a high side of the FET and the thermal sensing device, the resistor being disposed on a PCB external from the integrated circuit and connected to ground on a side of the resistor opposite the FET and the thermal sensing device.
Piston for an internal combustion engine having two gudgeon-pin bosses for the reception of a piston bolt, wherein the gudgeon-pin bosses have in each case when α = 180° (nadir) a nadir pocket which extend from a piston axis to the outside and the length of which is only a part of the length of the gudgeon-pin boss, characterised in that a gudgeon-pin boss axis deviates 0.1 - 1.0 mm from the piston axis.
An ex-vivo method of prognosis and/or diagnosis of infections of the lower respiratory tracts and lungs in a patient comprising determining the level of pancreatic stone protein / regenerating protein (PSP/reg) in a body fluid sample from said patient.